CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Other acquisition Director acquired 2,033 shares (other)
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-1 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Other acquisition Director acquired 2,112 shares (other)
- 4 Other acquisition Director acquired 2,112 shares (other)
- 8-K Event Executive or director change · Other events
- 8-K Event Bylaws or fiscal year change · Other events
- DEF 14A Proxy Proxy Statement
- 4 Other acquisition Director acquired 2,001 shares (other)
- 4 Other acquisition Director acquired 2,001 shares (other)
- 10-Q Report Quarterly Report
- 4 Other acquisition Director acquired 1,618 shares (other)
- 4 Other acquisition Director acquired 1,618 shares (other)
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 4 Other acquisition Director acquired 920 shares (other)
- 4 Other acquisition Director acquired 920 shares (other)
Page 28 of 82 · 1,637 filings